Microsoft says AI is spreading across the development workflow, but developers remain focused on IDE fundamentals and .NET modernization.

On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...

I constantly jump between draft articles, shopping lists, and random ideas. Until I found this shortcut, jumping between notes was annoying. Open any note and tap the three-dot menu in the top right ...

Transparent Note replaced Apple Notes for me. The UI is second to none in the note-taking app space. There is a limited free version. During my day, I take a lot of notes. I might be doing something ...

Apple Notes started out as a simple notetaking app. You quickly jot down your thoughts, add some images, make lists, share your lectures, and that's it. But over the years, the Notes app has developed ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

Recursive Superintelligence has raised $650 million at a $4.65 billion valuation in a funding round led by GV and Greycroft, according to the company. The round also included participation from AMD ...

Recursive Superintelligence, founded by former Google, Meta and OpenAI researchers, is part of a growing effort to automate the creation of artificial intelligence. By Cade Metz Reporting from San ...

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...